Intrinsic Value
CRISPR Therapeutics AG (CRSP)
$57.03
+1.37 (+2.46%)
Enterprise Value | -100,922,005,289,850,535,936 |
---|---|
Net Debt | -150.84 |
Equity Value | -100,922,005,289,850,535,936 |
Shares Outstanding | 79.22 |
Equity Value Per Share | -1,273,931,084,750,589,696.00 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt